ANXA1 and obesity due to melanocortin 4 receptor deficiency: Interestingly, the relationship between AnxA1, obesity, and obese-associated metabolic diseases has been well documented due to the role of AnxA1 in the treatment of type-2 diabetes [69,70,71,72].